{"id":"NCT00812006","sponsor":"Organon and Co","briefTitle":"A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03-24","primaryCompletion":"2009-10-22","completion":"2009-10-22","firstPosted":"2008-12-19","resultsPosted":"2011-01-27","lastUpdate":"2024-05-23"},"enrollment":108,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"rizatriptan benzoate","otherNames":["Maxalt"]},{"type":"DRUG","name":"Comparator: placebo","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"EXPERIMENTAL"},{"label":"C","type":"EXPERIMENTAL"}],"summary":"This study will provide additional efficacy data for rizatriptan when used for an acute migraine attack in patients already taking topiramate for migraine prophylaxis.","primaryOutcome":{"measure":"Pain Relief (PR)","timeFrame":"2 hours post dose","effectByArm":[{"arm":"Rizatriptan","deltaMin":105,"sd":null},{"arm":"Placebo","deltaMin":21,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22078129"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":101},"commonTop":["Somnolence","Nausea","Dizziness","Abdominal pain upper","Fatigue"]}}